Intranasal Delivery of Proteins and Peptides in the Treatment of Neurodegenerative Diseases - Wikidata - wikimedia - TriplyDB

Intranasal Delivery of Proteins and Peptides in the Treatment of Neurodegenerative Diseases

Intranasal Delivery of Proteins and Peptides in the Treatment of Neurodegenerative Diseases

http://www.wikidata.org/entity/Q35768362

about

Oxytocin and cardioprotection in diabetes and obesity Regulation of Bim in Health and Disease Hello from the Other Side: How Autoantibodies Circumvent the Blood-Brain Barrier in Autoimmune Encephalitis.Essential Oils May Lead α-Synuclein towards Toxic Fibrils Formation.Insulin resistance, dyslipidemia, and apolipoprotein E interactions as mechanisms in cognitive impairment and Alzheimer's disease The promise and pitfalls of intranasally administering psychopharmacological agents for the treatment of psychiatric disorders.Strategies for transporting nanoparticles across the blood-brain barrier.The SAMP8 mouse for investigating memory and the role of insulin in the brain.Peripheral Inflammation, Apolipoprotein E4, and Amyloid-β Interact to Induce Cognitive and Cerebrovascular Dysfunction.Role of serum albumin as a nanoparticulate carrier for nose-to-brain delivery of R-flurbiprofen: implications for the treatment of Alzheimer's disease.Increased acetylcholine and glutamate efflux in the prefrontal cortex following intranasal orexin-A (hypocretin-1).TopicalPdb: A database of topically delivered peptides.Recent Advances in the Therapeutic and Diagnostic Use of Liposomes and Carbon Nanomaterials in Ischemic Stroke

P2860

Q26748592-6362FCF4-24B2-4927-B7D9-CA1E4FB2E6CF Q26781203-2AA1809F-E771-41C0-8FCD-356EDCF3CB17 Q33586199-AA4C7BD1-42C6-4655-8418-A95D66647EE2 Q36973910-5C2779A2-A135-4B38-8977-8BF471FA4F40 Q37208538-8E688B48-4857-4A9E-BAAA-F5C44E174996 Q38629117-886625EB-AC70-469A-8D04-D98B191583BA Q38662677-B753AEE3-C9D8-4650-965E-82F10AD59190 Q39039983-38581D87-6572-43C3-B719-7F27A7B38723 Q41087339-44E3A2AE-B1B6-4044-8D43-3019A859C4EB Q42516901-A448CE22-6A0A-4630-89C6-62CF35B413FC Q47293244-4196413E-7B43-4AAD-A9E1-EA1BBB50B8EF Q50062495-4D2200B3-BF53-4C55-AA16-C57649074810 Q57177063-6AF71C2E-AA6D-4366-9A67-38EC4DDBA17D

P2860

Intranasal Delivery of Proteins and Peptides in the Treatment of Neurodegenerative Diseases

http://www.wikidata.org/entity/Q35768362

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Intranasal Delivery of Protein ...... of Neurodegenerative Diseases

@ast

Intranasal Delivery of Protein ...... of Neurodegenerative Diseases

@en

type

label

Intranasal Delivery of Protein ...... of Neurodegenerative Diseases

@ast

Intranasal Delivery of Protein ...... of Neurodegenerative Diseases

@en

prefLabel

Intranasal Delivery of Protein ...... of Neurodegenerative Diseases

@ast

Intranasal Delivery of Protein ...... of Neurodegenerative Diseases

@en

P1433

Q35768362-EBD042C1-FD25-4021-853E-5FB072394DD0

P1476

Q35768362-47F7E26C-9E1D-4F03-9EB3-BE885C80E835

P2093

Q35768362-64A3DC9C-E77A-4108-BEB5-A5FB463D0203

Q35768362-834D6E36-239B-4A49-BC27-4BFAF1276B3D

P2860

Q35768362-013BBBFC-181D-49BB-9E65-ACDDC2F33C22

Q35768362-077131E2-63B0-4D4A-9D56-4C7AC4262C9F

Q35768362-0B4E2D29-43D9-4690-9E64-A6CCD1AC937D

Q35768362-0F976076-4288-4677-A0C0-AB6C2D551A5F

Q35768362-11154999-5044-4B27-86F4-79690F6DE3C6

Q35768362-1223C0D1-879F-43A2-A309-A0461F7BBB96

Q35768362-14350B2F-A7A7-487C-9360-0E3C289657AE

Q35768362-1EE0FC87-128A-4BE1-98AB-7A022B8F90FB

Q35768362-22B26268-D871-44BD-98D6-0DB057BCDB9D

Q35768362-29E15ED9-A8C2-43DE-A7AD-A05566B8CACD

P2888

Q35768362-DD363438-A81D-4208-A3AB-EAA8006ABDCB

P304

Q35768362-807C9CF8-8DFC-4EA9-94CD-40DB600F435C

P31

Q35768362-FEF270B7-5E21-4245-9A22-34FBF090A653

P356

Q35768362-78FC12BD-0153-40EC-B11C-7B912403F4DA

P407

Q35768362-DC419210-48F7-415F-B193-E686A19302E3

P433

Q35768362-4B08443D-05F1-4E14-ACCF-46171034D241

P478

Q35768362-BD06DA76-3605-420F-9B29-E73B2230E701

P50

Q35768362-2E8FFE99-AA99-4FE5-BE0F-9C7DCA251776

P577

Q35768362-AB0A94BA-B4A5-4AA4-B73A-7D11929E0B5A

P6179

Q35768362-BE95BC42-4841-4CDB-BDD3-696A626E09C2

P698

Q35768362-53355F92-31F6-4185-AAE5-0E79F2F8E1C2

P921

Q35768362-F9294A32-0BEE-4734-AFED-A0AB334CE6C0

P932

Q35768362-7CCCB7A5-C5EB-4915-81EE-B4AF4C947482

P356

S12248-015-9719-7

P1433

The AAPS Journal

P1476

Intranasal Delivery of Protein ...... of Neurodegenerative Diseases

@en

P2093

M Elizabeth Meredith

http://www.w3.org/2001/XMLSchema#string

Therese S Salameh

http://www.w3.org/2001/XMLSchema#string

P2860

Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease

Anatomical and histological factors affecting intranasal drug and vaccine delivery

Genome-wide association studies in Alzheimer's disease

Insulin in the brain: there and back again

Glucagon-like peptide-1 receptor is involved in learning and neuroprotection

A new brain drug delivery strategy: focused ultrasound-enhanced intranasal drug delivery

Distribution and regulation of galanin-like peptide (GALP) in the hypothalamus of the mouse

Deficits in trace cued fear conditioning in galanin-treated rats and galanin-overexpressing transgenic mice.

High-dose albumin treatment for acute ischaemic stroke (ALIAS) Part 2: a randomised, double-blind, phase 3, placebo-controlled trial.

Sex and ApoE genotype differences in treatment response to two doses of intranasal insulin in adults with mild cognitive impairment or Alzheimer's disease.

P2888

s12248-015-9719-7

P304

780-787

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1208/S12248-015-9719-7

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

William A Banks

P577

2015-03-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1046221661

http://www.w3.org/2001/XMLSchema#string

P698

25801717

http://www.w3.org/2001/XMLSchema#string

P921

neurodegeneration

P932

4476983

http://www.w3.org/2001/XMLSchema#string